Skip to main content

Table 2 Summary of immunohistochemistry showing hMLH-1, hMSH-2 and EGFR expression

From: Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours

Expression

No. patients (N = 56)

(%)

hMLH-1

 Null

4

7.1

 Low

23

41.1

 Normal

29

51.8

hMSH-2

 Null

1

1.9

 Low

15

26.7

 Normal

40

71.4

EGFR

 Positive

17

30.4

 Negative

39

69.6